Alex Garvie. Aeschylus' Supplices. Play and Trilogy, Bristol Phoenix Press, UK, 2006, i-xxiv + 279 pp.

Fil: Fernández Deagustini, María del Pilar. Universidad Nacional de La Plata. Facultad de Humanidades y Ciencias de la Educación; Argentina.

Alex Garvie. Aeschylus' Supplices. Play and Trilogy, Bristol Phoenix Press, UK, 2006, i-xxiv + 279 pp.

Fil: Fernández Deagustini, María del Pilar. Universidad Nacional de La Plata. Facultad de Humanidades y Ciencias de la Educación; Argentina.

1969 University of Michigan Football Team

1967 University of Michigan Football Team

1968 University of Michigan Football Team

Locker room celebration, UM Football, 1969 UM-Ohio State game

[Garvie Craw, #48; Jim Mandich, #88; Jack Harpring, #71

Análise de biomarcadores sanguíneos em estímulos anaeróbios máximos no nado crawl

Universidade Estadual de Campinas . Faculdade de Educação Física

Using children’s literature in ELT: A story-based approach

There has been a growing interest in the role of children’s literature in language teaching since the 80s, when the communicative approach made it possible to bring stories into the classroom (Garvie, 1990). It is undeniable that storytelling has many benefits. Not only are children naturally drawn to stories, but they are also an effective and enjoyable way to teach and learn. This article presents the findings of a MA project on using stories with children. It shows the importance of stories on language acquisition and concludes with some practical suggestions based on my teaching experience with young learners.

Efeito do envelhecimento In Vitro na transformação de fase cristalina da Y-TZP: análise topográfica, mecânica e cristalográfica

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Quantitative phase analysis from X-ray diffraction in Y-TZP dental ceramics: A critical evaluation

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Moduli spaces of (G,h)-constellations

Given a reductive group G acting on an affine scheme X over C and a Hilbert function h: Irr G → N_0, we construct the moduli space M_Ө(X) of Ө-stable (G,h)-constellations on X, which is a common generalisation of the invariant Hilbert scheme after Alexeev and Brion and the moduli space of Ө-stable G-constellations for finite groups G introduced by Craw and Ishii. Our construction of a morphism M_Ө(X) → X//G makes this moduli space a candidate for a resolution of singularities of the quotient X//G. Furthermore, we determine the invariant Hilbert scheme of the zero fibre of the moment map of an action of Sl_2 on (C²)⁶ as one of the first examples of invariant Hilbert schemes with multiplicities. While doing this, we present a general procedure for the realisation of such calculations. We also consider questions of smoothness and connectedness and thereby show that our Hilbert scheme gives a resolution of singularities of the symplectic reduction of the action.

The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.

Second-generation antipsychotics (SGAs) are increasingly prescribed to treat psychiatric symptoms in pediatric patients infected with HIV. We examined the relationship between prescribed SGAs and physical growth in a cohort of youth with perinatally acquired HIV-1 infection. Pediatric AIDS Clinical Trials Group (PACTG), Protocol 219C (P219C), a multicenter, longitudinal observational study of children and adolescents perinatally exposed to HIV, was conducted from September 2000 until May 2007. The analysis included P219C participants who were perinatally HIV-infected, 3-18 years old, prescribed first SGA for at least 1 month, and had available baseline data prior to starting first SGA. Each participant prescribed an SGA was matched (based on gender, age, Tanner stage, baseline body mass index [BMI] z score) with 1-3 controls without antipsychotic prescriptions. The main outcomes were short-term (approximately 6 months) and long-term (approximately 2 years) changes in BMI z scores from baseline. There were 236 participants in the short-term and 198 in the long-term analysis. In linear regression models, youth with SGA prescriptions had increased BMI z scores relative to youth without antipsychotic prescriptions, for all SGAs (short-term increase = 0.192, p = 0.003; long-term increase = 0.350, p < 0.001), and for risperidone alone (short-term = 0.239, p = 0.002; long-term = 0.360, p = 0.001). Participants receiving both protease inhibitors (PIs) and SGAs showed especially large increases. These findings suggest that growth should be carefully monitored in youth with perinatally acquired HIV who are prescribed SGAs. Future research should investigate the interaction between PIs and SGAs in children and adolescents with perinatally acquired HIV infection.

Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.

OBJECTIVE: To examine the relationships between physical growth and medications prescribed for symptoms of attention-deficit hyperactivity disorder in children with HIV. METHODS: Analysis of data from children with perinatally acquired HIV (N = 2251; age 3-19 years), with and without prescriptions for stimulant and nonstimulant medications used to treat attention-deficit hyperactivity disorder, in a long-term observational study. Height and weight measurements were transformed to z scores and compared across medication groups. Changes in z scores during a 2-year interval were compared using multiple linear regression models adjusting for selected covariates. RESULTS: Participants with (n = 215) and without (n = 2036) prescriptions were shorter than expected based on US age and gender norms (p < .001). Children without prescriptions weighed less at baseline than children in the general population (p < .001) but gained height and weight at a faster rate (p < .001). Children prescribed stimulants were similar to population norms in baseline weight; their height and weight growth velocities were comparable with the general population and children without prescriptions (for weight, p = .511 and .100, respectively). Children prescribed nonstimulants had the lowest baseline height but were similar to population norms in baseline weight. Their height and weight growth velocities were comparable with the general population but significantly slower than children without prescriptions (p = .01 and .02, respectively). CONCLUSION: The use of stimulants to treat symptoms of attention-deficit hyperactivity disorder does not significantly exacerbate the potential for growth delay in children with HIV and may afford opportunities for interventions that promote physical growth. Prospective studies are needed to confirm these findings.